It’s been 40 years since HIV rocked the pharma industry, but while treatments have been identified to help patients manage the virus, a HIV vaccine has remained elusive. To find out why, we explore the current state of HIV research and the challenges that stand in the way of vaccine development. Elsewhere in vaccines, we take a look at the AI software Opyl, which could help researchers predict the success of Covid-19 vaccine candidates.
Also in this issue, we investigate cancer treatment disparity in Europe, examine the potential of a drug tracking app that gives patients a platform to openly review their medications, and speak to Novo Ventures about investing in niche drug development in the middle of a pandemic.
Plus, after Covid-19 vaccine developers vowed not to file for approval without first demonstrating positive Phase III trial results, we find out what makes Phase III clinical trials so important, learn about plant-based medicine production and explore ways that air freight hubs worldwide are preparing for an influx of in-demand Covid-19 treatments and vaccines.
Editor | Eloise McLennan
Commissioning Editor | Daniel Garrun
Writers | Allie Nawrat, Natalie Healey, Abi Millar, Chloe Kent
Magazine Designer | Marzia Del Gaone
Graphic Designers | Anett Arc, Ashley McPherson, Tyrrell Lowe, Noemi Balint, Petra Konyi-Kiss, Maria Gimenez, Filipe Costa, Martina Labaiova
Lead Designer | John Hammond
Publisher | Susanne Hauner
Digital Publishing Director | Duncan West
Sales Manager | Nimai Amin
+44 (0) 207 936 6453
For media partnership enquiries please contact: Susanne Hauner
Pharma Technology focus is powered by h5mag
read past issues of pharma technology focus HERE
Copyright 2020 NRi Digital, a trading division of Verdict Media Ltd. Registered office John Carpenter House, John Carpenter Street, London, EC4Y 0AN, UK. Company registration number 03171601. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronic, photocopying or otherwise, without prior permission of the publisher and copyright owner. While every effort has been made to ensure the accuracy of this publication, the publisher accepts no responsibility for errors or omissions. The products and services advertised are those of individual authors and are not necessarily endorsed by or connected with the publisher. The opinions expressed in the articles within this publication are those of individual authors and not necessarily those of the publisher.